Intraoperative Detection and Management of Euglycemic Ketonemia During Emergency Surgery Using Point-of-Care Blood Beta-Hydroxybutyrate Testing in a Patient Receiving Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors: A Case Report
Abstract
Patients who receive sodium-glucose cotransporter 2 inhibitors (SGLT2is) are at risk of developing euglycemic ketoacidosis (EDKA), particularly during the perioperative period, if drug withdrawal is insufficient. Although current guidelines recommend withholding SGLT2is prior to surgery, adequate withdrawal periods cannot always be ensured in emergency situations. However, to date, no standardized intraoperative management strategies have been established to address this risk in such situations. To address this gap, we developed a prototype intraoperative management regimen at our institution specifically for patients undergoing emergency surgery without sufficient SGLT2i withdrawal. This regimen was established on the basis of previously reported strategies for managing EDKA and included point-of-care blood beta-hydroxybutyrate (BHB) testing as a key intraoperative monitoring tool. In this case report, we describe the successful application of this regimen in an emergency surgical setting, resulting in stable intraoperative metabolic control without the development of ketoacidosis.
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- The Role of AMPK Activation for Cardioprotection in Doxorubicin-Induced Cardiotoxicity
- Hypoglycemic medicines in the treatment of Alzheimer’s disease: Pathophysiological links between AD and glucose metabolism
- Isorhamnetin Reduces Glucose Level, Inflammation, and Oxidative Stress in High-Fat Diet/Streptozotocin Diabetic Mice Model
- Modulating Sirtuin Biology and Nicotinamide Adenine Diphosphate Metabolism in Cardiovascular Disease—From Bench to Bedside
- Characterization of the SGLT2 Interaction Network and Its Regulation by SGLT2 Inhibitors: A Bioinformatic Analysis
- Early Treatment with Empagliflozin and GABA Improves β-Cell Mass and Glucose Tolerance in Streptozotocin-Treated Mice
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.